<

 
Data updated 2025-07-23 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date08847113.1 (espacenet)  (Federated)  (European Patent Register), 20081107
Patent/reg. no. and dateDK/EP 2205244, 20130821
Publication date20100714
Priority no. and dateUS 2583 P, 20071108, US 5803 P, 20071207, US 98676 P, 20080919, US 112060 P, 20081106
EP pub. no. and date EP 2205244 20100714
Effective date
Applicant/ownerAmbit Biosciences Corporation,
11080 Roselle Street
San Diego, CA 92121, US
Applicant ref. no.P81313843DK00E
InventorJAMES, Joyce, K., 1931 Chalcedony Street
San Diego
CA 92109, US,
EICHELBERGER, Shawn R., 4215 Sorrento Valley Blvd.
San Diego, CA 92121, US,
SAVALL, Traci L., 4215 Sorrento Valley Blvd.
San Diego, CA 92121, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 31/5377 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) 
TitleFREMGANGSMÅDER TIL INDGIVELSE AF N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N'-{4-[7-(2-MORPHOLIN-4-YL-ETHOXY-)IMIDAZO-[2,1-B]-[1,3]-BENZOTHIAZOL-2-YL]-PHENYL}URINSTOF TIL BEHANDLING AF PROLIFERATIV SYGDOM
Int. application no.US2008012539
Int. publication no.WO2009061446
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact